RCA
NAVB

Runnymede Capital Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Runnymede Capital Advisors’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5
Closed – – 293
2025
Q1 		$0 Hold
5
– – ﹤0.01% 314
2024
Q4 		$0 Buy
+5
New – ﹤0.01% 285